Kairos Pharma, Ltd.
KAPA
$0.85
-$0.01-1.05%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 83.75% | -16.10% | 184.28% | -60.46% | 15,219.05% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -72.73% | 60.00% | 44.74% | 280.00% | -41.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -38.44% | -27.83% | -16.79% | 88.71% | -- |
| Total Current Assets | 37.55% | -20.02% | 45.12% | -12.08% | 12,378.95% |
|
|
|||||
| Total Current Assets | 37.55% | -20.02% | 45.12% | -12.08% | 12,378.95% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -28.17% | -21.98% | -18.02% | -15.27% | -13.25% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -22.70% | -0.76% | 23.82% | -- | -- |
| Total Assets | 20.88% | -15.93% | 37.60% | 15.27% | 385.83% |
|
|
|||||
| Total Accounts Payable | -40.53% | -16.02% | -18.85% | -35.16% | -47.26% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 33.96% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -40.53% | -16.02% | -18.85% | -40.67% | -44.40% |
|
|
|||||
| Total Current Liabilities | -40.53% | -16.02% | -18.85% | -40.67% | -44.40% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 33.96% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -40.53% | -16.02% | -18.85% | -40.67% | -54.61% |
|
|
|||||
| Common Stock & APIC | 17.52% | 4.61% | 23.06% | 21.71% | 170.13% |
| Retained Earnings | -12.16% | -14.11% | -14.32% | -12.51% | -15.42% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 27.80% | -15.91% | 49.33% | 43.34% | 225.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 27.80% | -15.91% | 49.33% | 43.34% | 225.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.80% | -15.91% | 49.33% | 43.34% | 225.55% |
|
|
|||||